diaziquone has been researched along with Adenocarcinoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barranco, SC; Boerwinkle, WR; Howell, KA; Rubin, NH; Schechter, GA | 1 |
Baker, LH; Decker, DA; Haas, CD; Samson, MK | 1 |
Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ; van Hazel, GA | 1 |
Gutierrez, PL; Ngo, EO; Nutter, LM; Sura, T | 1 |
Ball, H; Blessing, JA; Rettenmaier, M; Slayton, RE | 1 |
Fleming, T; Guy, JT; Pugh, RP; Ward, JH; Weick, JK | 1 |
Bonnett, JD; Coltman, CA; Fleming, T; Harker, G; Mills, G; Natale, RB; Oishi, N; Tilchen, EJ | 1 |
Al-Sarraf, M; Decker, DA; Goldfarb, S; Kish, J | 1 |
Baker, LH; Fletcher, WS; McCracken, JD; O'Bryan, RM; Shildt, R; Stephens, RL; Subramanian, VP | 1 |
9 other study(ies) available for diaziquone and Adenocarcinoma
Article | Year |
---|---|
Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro.
Topics: Adenocarcinoma; Animals; Astrocytoma; Aziridines; Azirines; Benzoquinones; Cell Division; Cell Line; Cell Survival; Cricetinae; Cricetulus; Female; Humans; Kinetics; Ovary; Stomach Neoplasms | 1983 |
Phase II clinical evaluation of AZQ in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1984 |
A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Thrombocytopenia | 1982 |
Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Benzoquinones; Breast Neoplasms; Humans; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Drugs, Investigational; Female; Humans; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1989 |
Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
Topics: Adenocarcinoma; Aged; Aziridines; Azirines; Benzoquinones; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1989 |
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1987 |
Phase II clinical evaluation of AZQ in renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Thrombocytopenia | 1986 |
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Thrombocytopenia | 1985 |